change:healthcare has been chosen by GeneSyn IP Ventures, LLC, a partner of the Keystone Institute for Translational Medicine in Philadelphia, Penn., to support a national translational medicine technology consortium, officials announced today.
The move is intended to help the Keystone Institute for Translational Medicine more quickly reach their goal of increasing the speed with which medical [...]
From the category archives: